239 related articles for article (PubMed ID: 24942472)
1. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
2. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.
Zou J; Zhang W; Li XL
Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931
[TBL] [Abstract][Full Text] [Related]
3. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
5. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
[TBL] [Abstract][Full Text] [Related]
6. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
7. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.
Yang J; Yang D; Sun Y; Sun B; Wang G; Trent JC; Araujo DM; Chen K; Zhang W
Cancer; 2011 Nov; 117(21):4925-38. PubMed ID: 21495021
[TBL] [Abstract][Full Text] [Related]
8. APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.
Yang J; Yang D; Cogdell D; Du X; Li H; Pang Y; Sun Y; Hu L; Sun B; Trent J; Chen K; Zhang W
Technol Cancer Res Treat; 2010 Apr; 9(2):161-9. PubMed ID: 20218738
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
10. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.
Liu C; Tu Y; Sun X; Jiang J; Jin X; Bo X; Li Z; Bian A; Wang X; Liu D; Wang Z; Ding L
Clin Exp Med; 2011 Jun; 11(2):105-12. PubMed ID: 20809334
[TBL] [Abstract][Full Text] [Related]
15. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/β-catenin signaling pathway.
Wang Y; Sun S; Xu J; Luo Y; Xin Y; Zhao X
Oncol Rep; 2018 Feb; 39(2):589-596. PubMed ID: 29207112
[TBL] [Abstract][Full Text] [Related]
17. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line.
Tao H; Chen F; Liu H; Hu Y; Wang Y; Li H
Mol Med Rep; 2017 Aug; 16(2):1701-1706. PubMed ID: 28656199
[TBL] [Abstract][Full Text] [Related]
19. Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway.
Sha L; Ma D; Chen C
Aging (Albany NY); 2020 Dec; 12(23):23598-23608. PubMed ID: 33310972
[TBL] [Abstract][Full Text] [Related]
20. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.
Cleton-Jansen AM; Anninga JK; Briaire-de Bruijn IH; Romeo S; Oosting J; Egeler RM; Gelderblom H; Taminiau AH; Hogendoorn PC
Br J Cancer; 2009 Dec; 101(11):1909-18. PubMed ID: 19888226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
